Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non–small-cell lung cancer: Which is better?

Jemal, 2001, Recent trends in lung cancer mortality in the United States, J Natl Cancer Inst, 93, 277, 10.1093/jnci/93.4.277 Free, 2007, Lung cancer outcomes at a UK cancer unit between 1998–2001, Lung Cancer, 57, 222, 10.1016/j.lungcan.2007.03.006 Okada, 2001, Is segmentectomy with lymph node assessment an alternative to lobectomy for nonsmall cell lung cancer of 2 cm or smaller?, Ann Thorac Surg, 71, 956, 10.1016/S0003-4975(00)02223-2 Onishi, 2004, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study, Cancer, 101, 1623, 10.1002/cncr.20539 Nakamura, 2010, A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L), Jpn J Clin Oncol, 40, 271, 10.1093/jjco/hyp156 Glazer, 1984, The mediastinum in non-small cell lung cancer: CT-surgical correlation, AJR Am J Roentgenol, 142, 1101, 10.2214/ajr.142.6.1101 Glazer, 1985, Imaging of the pulmonary hilum: A prospective comparative study in patients with lung cancer, AJR Am J Roentgenol, 145, 245, 10.2214/ajr.145.2.245 Martini, 1985, Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma, J Thorac Cardiovasc Surg, 90, 639, 10.1016/S0022-5223(19)38529-0 Musset, 1986, Primary lung cancer staging: Prospective comparative study of MR imaging with CT, Radiology, 160, 607, 10.1148/radiology.160.3.2426726 Laurent, 1988, Bronchogenic carcinoma staging: CT versus MR imaging-assessment with surgery, Eur J Cardiothorac Surg, 2, 31, 10.1016/1010-7940(88)90093-0 Nolop, 1987, Glucose utilization in vivo by human pulmonary neoplasms, Cancer, 60, 2682, 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H Van Tinteren, 2002, Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non small cell lung cancer: The PLUS multicentre randomized trial, Lancet, 359, 1388, 10.1016/S0140-6736(02)08352-6 Viney, 2004, Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non small cell lung cancer, J Clin Oncol, 22, 2357, 10.1200/JCO.2004.04.126 Herder, 2006, Traditional versus up front [18F]fluorodeoxyglucose-positron emission tomography staging of non small cell lung cancer: A Dutch cooperative randomized study, J Clin Oncol, 24, 1800, 10.1200/JCO.2005.02.4695 Fischer, 2009, Preoperative staging of lung cancer with combined PET-CT, N Eng J Med, 361, 32, 10.1056/NEJMoa0900043 Maziak, 2009, Positron emission tomography in staging early lung cancer: A randomized trial, Ann Intern Med, 151, 221, 10.7326/0003-4819-151-4-200908180-00132 Lardinois, 2003, Staging of non–small-cell lung cancer with integrated positron-emission-tomography and computed tomography, N Engl J Med, 348, 2500, 10.1056/NEJMoa022136 Nomori, 2008, Diffusion weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results, J Thorac Cardiovasc Surg, 135, 816, 10.1016/j.jtcvs.2007.10.035 Chen, 2010, Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non–small-cell lung cancer: How do they measure up?, Magn Reson Imaging, 28, 613, 10.1016/j.mri.2010.02.009 Koh, 2007, Diffusion-weighted MRI in the body: Applications and challenges in oncology, AJR Am J Roentgenol, 188, 1622, 10.2214/AJR.06.1403 Whiting, 2003, The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Med Res Methodol, 3, 25, 10.1186/1471-2288-3-25 Rutter, 2001, A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations, Stat Med, 20, 2865, 10.1002/sim.942 Ohno, 2008, Non-small cell lung cancer: Whole-body MR examination for M-stage assessment—Utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT, Radiology, 248, 643, 10.1148/radiol.2482072039 Koşucu, 2009, Mediastinal lymph nodes: Assessment with diffusion-weighted MR imaging, J Magn Reson Imaging, 30, 292, 10.1002/jmri.21850 Shinya, 2009, Dual-timepoint F-18FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer, Clin Nucl Med, 34, 216, 10.1097/RLU.0b013e31819a1f3d Zhang, 2006, Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis, Ai Zheng, 25, 66 Liu, 2007, Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non–small-cell lung cancer patients, Zhonghua Zhong Liu Za Zhi, 29, 453 Bryant, 2006, The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers, J Thorac Cardiovasc Surg, 132, 1363, 10.1016/j.jtcvs.2006.07.032 Al-Sarraf, 2007, Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography, Interact Cardiovasc Thorac Surg, 6, 350, 10.1510/icvts.2006.150664 Hsu, 2007, Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography, Respirology, 12, 848, 10.1111/j.1440-1843.2007.01164.x Al-Sarraf, 2008, Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography, Eur J Cardiothorac Surg, 33, 104, 10.1016/j.ejcts.2007.09.026 Gomez-Caro, 2010, Incidence of occult mediastinal node involvement in cN0 non–small-cell lung cancer patients after negative uptake of positron emission tomography/computed tomography scan, Eur J Cardiothorac Surg, 37, 1168, 10.1016/j.ejcts.2009.12.013 Lee, 2009, Integrated positron emission tomography for nodal staging in lung cancer, Asian Cardiovasc Thorac Ann, 17, 622, 10.1177/0218492309349253 Liu, 2009, Accuracy of 18F-FDG PET/CT for lymph node staging in non–small-cell lung cancers, Chin Med J, 122, 1749 Kanzaki, 2011, Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study, Lung Cancer, 71, 333, 10.1016/j.lungcan.2010.06.008 Autoch, 2003, Non-small cell lung cancer: Dual-modality PET-CT in preoperative staging, Radiology, 229, 526, 10.1148/radiol.2292021598 Ma, 2011, Differential diagnosis of mediastinal lymph node metastasis in lung cancer patients using 18F-FDG PET/CT with double quantitative SUVmax and CT value, Chin J Clin Oncol, 38, 284 Toba, 2010, Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer, J Med Invest, 57, 305, 10.2152/jmi.57.305 Morikawa, 2009, The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax, J Nucl Med, 50, 81, 10.2967/jnumed.108.056408 Usuda, 2011, Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers, Ann Thorac Surg, 91, 1689, 10.1016/j.athoracsur.2011.02.037 Sánchez Sánchez, 2011, Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2), Rev Esp Med Nucl, 30, 211, 10.1016/j.remn.2011.02.010 Iskender, 2011, Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography/computerised tomography in patients with non–small-cell lung cancer, Interact Cardio Vasc Thorac Surg, 12, 965, 10.1510/icvts.2010.258103 Fischer, 2011, Multimodality approach to mediastinal staging in non-small cell lung cancer: Faults and benefits of PET-CT: A randomised trial, Thorax, 66, 294, 10.1136/thx.2010.154476 Perigaud, 2009, Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non–small-cell lung cancer, Eur J Cardiothorac Surg, 36, 731, 10.1016/j.ejcts.2009.05.044 Hwangbo, 2009, Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer, Chest, 135, 1280, 10.1378/chest.08-2019 Ohno, 2011, N stage disease in patients with non-small cell lung cancer: Efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT, Radiology, 261, 605, 10.1148/radiol.11110281 Li M, Wu N, Liu Y, et al. Regional nodal staging with (18)F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging. Eur J Radiol Epub 2011 Apr 19. Li X, Zhang H, Xing L, et al. Mediastinal lymph nodes staging by (18)F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study. Radiother Oncol Epub 2011 Nov 17. Kubota, 2011, Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: A Japanese multicenter clinical study, Ann Nucl Med, 25, 777, 10.1007/s12149-011-0529-4 Hu, 2011, Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non–small-cell lung cancer patients with lung comorbidity, Clin Nucl Med, 36, 429, 10.1097/RLU.0b013e3182173810 Darling, 2011, Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: Results of mediastinal staging in the early lung positron emission tomography trial, J Thorac Oncol, 6, 1367, 10.1097/JTO.0b013e318220c912 Nakayama, 2010, Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient, J Comput Assist Tomogr, 34, 1, 10.1097/RCT.0b013e3181a9cc07 Tasci, 2010, The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer, Interact Cardiovasc Thorac Surg, 10, 200, 10.1510/icvts.2009.220392 Li, 2010, Value of positron emission tomography-computed tomography in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer, Nan Fang Yi Ke Da Xue Xue Bao, 30, 506 Jeon, 2010, Incremental value of PET/CT over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis, AJR Am J Roentgenol, 195, 370, 10.2214/AJR.09.3772 Sanli, 2009, Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 138, 1200, 10.1016/j.jtcvs.2009.03.035 Lee, 2009, 18F-FDG PET/CT in mediastinal lymph node staging of non–small-cell lung cancer in a tuberculosis-endemic country: Consideration of lymph node calcification and distribution pattern to improve specificity, Eur J Nucl Med Mol Imaging, 36, 1794, 10.1007/s00259-009-1155-4 Billé, 2009, Preoperative intrathoracic lymph node staging in patients with non–small-cell lung cancer: Accuracy of integrated positron emission tomography and computed tomography, Eur J Cardiothorac Surg, 36, 440, 10.1016/j.ejcts.2009.04.003 Hasegawa, 2008, Mediastinal lymph nodes in patients with non–small cell lung cancer: Preliminary experience with diffusion-weighted MR imaging, J Thorac Imaging, 23, 157, 10.1097/RTI.0b013e318166d2f5 Yang, 2008, Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer, Lung Cancer, 61, 35, 10.1016/j.lungcan.2007.11.007 Plathow, 2008, Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced non-small cell lung cancer: Initial results, Invest Radiol, 43, 290, 10.1097/RLI.0b013e318163273a Lee, 2007, Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer, J Thorac Cardiovasc Surg, 133, 746, 10.1016/j.jtcvs.2006.10.043 Kim, 2007, Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis endemic country: Diagnostic efficacy in 674 patients, Cancer, 109, 1068, 10.1002/cncr.22518 Halpern, 2005, Presurgical staging of non-small cell lung cancer: Positron emission tomography, integrated positron emission tomography/CT, and software image fusion, Chest, 128, 2289, 10.1378/chest.128.4.2289 Roberts, 2000, Factors associated with false positive staging of lung cancer by positron emission tomography, Ann Thorac Surg, 70, 1154, 10.1016/S0003-4975(00)01769-0 Kosucu, 2009, Mediastinal lymph nodes: Assessment with diffusion-weighted MR imaging, J Magn Reson Imaging, 30, 292, 10.1002/jmri.21850 Jaeschke, 1994, Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group, JAMA, 271, 703, 10.1001/jama.1994.03510330081039